Triatec and Lung infection - a phase IV clinical study of FDA data

Summary:

Lung infection is reported as a side effect among people who take Triatec (ramipril), especially for people who are female, 50-59 old, also take Lipitor, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Lung infection when taking Triatec. It is created by eHealthMe based on reports of 4,124 people who have side effects when taking Triatec from the FDA, and is updated regularly.

What is Triatec?

Triatec has active ingredients of ramipril. eHealthMe is studying from 4,133 Triatec users. Check the latest studies of Triatec.

What is Lung infection?

Lung infection is found to be associated with 1,061 drugs and 1,317 conditions by eHealthMe. Check the latest studies of Lung infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

4,124 people reported to have side effects when taking Triatec.
Among them, 15 people (0.36%) have Lung infection.

Among these 15 people:

What is the gender of people who have Lung infection when taking Triatec? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Lung infection when taking Triatec? *

What are other drugs people take besides Triatec? *

What are other side effects people have besides Lung infection? *

Joint Pain: 9 people, 60.00%
Pain: 7 people, 46.67%
Blood Glucose Increased: 7 people, 46.67%
High Blood Pressure: 7 people, 46.67%
Vein Disorder: 7 people, 46.67%
Arthropathy: 7 people, 46.67%
Cataract (clouding of the lens inside the eye): 7 people, 46.67%
Blood Pressure Fluctuation: 6 people, 40.00%
Dyspnea (difficult or laboured breathing): 6 people, 40.00%
Pain In Extremity: 5 people, 33.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 46.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 13.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Triatec and have Lung infection?

- Check whether Lung infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triatec:

Triatec (4,133 reports)

Lung infection treatments and more:

Lung infection (25,183 reports)

Browse all side effects of Triatec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung infection:

Lung infection (1,061 drugs)

Browse all the conditions that are associated with Lung infection:

Lung infection (1,317 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Triatec) and Triatec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.